Charles River Analyst Price Targets

Charles River Laboratories International Inc

CRLNYSE

$288.50

-4.85-1.65%

al cierre: Sep 4, 5:00 PM EST

$288.50

N/A

After hour: Sep 4, 4:15 PM EST

Wall Street analyst price targets and consensus rating for Charles River (CRL).

Price Target Range — 13 Quarters

Analyst Consensus — 19 Analysts

12Buy

7Hold

Consensus RatingBuy# Analysts19Avg. Consensus PT$236Upside to Avg. PT-18.2%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 10, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$235→$300
Aug 7, 2026	Morgan Stanley	Ricky Goldwasser	PT Raise	Overweight	$260→$300
Aug 6, 2026	RBC Capital	Ryan Halsted	PT Raise	Outperform	$215→$282
Aug 6, 2026	Evercore ISI Group	Ross Muken	PT Raise	Outperform	$260→$300
Aug 6, 2026	JP Morgan	Casey Woodring	Upgrade	Neutral→Overweight	$180→$310
Jul 20, 2026	CLSA	Michael Luo	Downgrade	Outperform→Hold	$219
Jul 13, 2026	Mizuho	Ann Hynes	PT Raise	Neutral	$192→$230
Jul 9, 2026	Morgan Stanley	Ricky Goldwasser	PT Raise	Overweight	$220→$260
Jun 17, 2026	Morgan Stanley	Ricky Goldwasser	Upgrade	Equal-Weight→Overweight	$185→$220
May 29, 2026	CLSA	Michael Luo	Upgrade	Hold→Outperform	$167→$219
May 8, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$210→$220
May 8, 2026	Evercore ISI Group	Ross Muken	PT Raise	Outperform	$200→$220
Apr 14, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$200→$210
Apr 13, 2026	JP Morgan	Casey Woodring	PT Cut	Neutral	$165→$160
Feb 25, 2026	UBS	Dan Leonard	PT Raise	Neutral	$170→$175
Feb 20, 2026	TD Cowen	Charles Rhyee	PT Cut	Buy	$251→$235
Feb 20, 2026	Mizuho	Ann Hynes	PT Cut	Neutral	$215→$175
Feb 19, 2026	Barclays	Luke Sergott	PT Cut	Overweight	$215→$200
Feb 19, 2026	Evercore ISI Group	Ross Muken	PT Cut	Outperform	$260→$200
Jan 16, 2026	Citigroup	Patrick Donnelly	PT Raise	Buy	$200→$265